JORDAN RENTZ: Open Payments
NPI 1780274050 · MOULTRIE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$279 in 13 payments from 9 companies in 2025. Trend: 2023 $108 · 2024 $266 · 2025 $279
Food & beverage: $279
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 5 | $101 |
| Pacira Pharmaceuticals Incorporated | 1 | $28 |
| GlaxoSmithKline, LLC. | 1 | $25 |
| Mallinckrodt Hospital Products Inc. | 1 | $23 |
| Lilly USA, LLC | 1 | $22 |
| Ardelyx, Inc. | 1 | $21 |
| Aimmune Therapeutics, Inc. | 1 | $20 |
| Novo Nordisk Inc | 1 | $20 |
| Intercept Pharmaceuticals, Inc. | 1 | $19 |
Products named: TREMFYA, Exparel, BENLYSTA, ACTHAR, OMVOH, IBSRELA, ZENPEP, Wegovy.
Industry payments across GA — which companies pay providers there.
